معرفی
Bowen Li is an Assistant Professor at the University of Toronto, affiliated with the Leslie Dan Faculty of Pharmacy and cross-appointed in the Institute of Biomedical Engineering and Department of Chemistry. His research focuses on high-throughput development of nanoparticles for RNA medicine delivery, leveraging combinatorial chemistry and artificial intelligence (DSAI) to accelerate material design and screening. He holds a PhD from the University of Washington (2019) and completed postdoctoral studies at MIT (2019–2022).
**Research Interests:** Biological Chemistry, Organic Chemistry, and Polymer/ Material Chemistry. His lab pioneers DSAI-driven platforms for lipid nanoparticle (LNP) design, enabling rapid synthesis and screening of thousands of lipid variants for tissue-specific nucleic acid delivery. Key innovations include autonomous discovery systems like LUMI-lab and modular synthesis strategies for biodegradable ionizable lipids.
**Articles Trends:** Recent work emphasizes mRNA delivery optimization, lung-targeted therapies, and immunomodulatory materials. Over 15 publications (2023–2025) highlight advancements in nanoparticle design, organ-specific targeting, and overcoming therapeutic resistance in cancer and cardiovascular contexts.
**Awards:** None explicitly stated in provided texts. **Grants/Advising:** Details not provided. **Labs/Teams:** Leads the Li Research Group at U of T, integrating data science and biomaterials for RNA nanomedicine applications in vaccines, immunotherapy, and regenerative medicine.
